Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.

Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.

Item
http://www.wikidata.org/entity/Q40209464
Evaluation of encapsulated liver cell spheroids in a fluidised-bed bioartificial liver for treatment of ischaemic acute liver failure in pigs in a translational settingPivotal preclinical trial of the spheroid reservoir bioartificial liverGene expression profiling and network analysis reveals lipid and steroid metabolism to be the most favored by TNFalpha in HepG2 cells.Zonation related function and ubiquitination regulation in human hepatocellular carcinoma cells in dynamic vs. static culture conditionsThe early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics.Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.Wnt/β-Catenin Signaling Regulates the Expression of the Ammonium Permease Gene RHBG in Human Cancer Cells.Transcriptome profiling identifies p53 as a key player during calreticulin deficiency: Implications in lipid accumulation.Bioengineering the liver: scale-up and cool chain delivery of the liver cell biomass for clinical targeting in a bioartificial liver support system.Alleviating liver failure conditions using an integrated hybrid cryogel based cellular bioreactor as a bioartificial liver support.Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.Primary-like human hepatocytes genetically engineered to obtain proliferation competence display hepatic differentiation characteristics in monolayer and organotypical spheroid cultures.Therapeutic evaluation of a microbioartificial liver with recombinant HepG2 cells for rats with hepatic failure.Stable overexpression of arginase I and ornithine transcarbamylase in HepG2 cells improves its ammonia detoxification.Optimization of mass transfer for toxin removal and immunoprotection of hepatocytes in a bioartificial liver.Human monocyte-derived cells with individual hepatocyte characteristics: a novel tool for personalized in vitro studies.A clinical-scale BioArtificial Liver, developed for GMP, improved clinical parameters of liver function in porcine liver failure.
P2860

Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.

Item
http://www.wikidata.org/entity/Q40209464
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Ornithine transcarbamylase and ...... epatoblastoma cell line HepG2.
@en
type
label
Ornithine transcarbamylase and ...... epatoblastoma cell line HepG2.
@en
prefLabel
Ornithine transcarbamylase and ...... epatoblastoma cell line HepG2.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Ornithine transcarbamylase and ...... epatoblastoma cell line HepG2.
@en
P2093
P304
P31
P356
10.1016/J.BIOCEL.2006.10.007
P433
P478
P50
P577
P698